Regadenoson Real Time Perfusion Imaging Trial-Optison

Clinical trial NCT01489176 · COMPLETED

Trial details

NCT number: NCT01489176
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease Myocardial Perfusion Abnormalities

Start date: 2012-07-31
Primary completion: 2014-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.